PERSISTENCE OF CIRCULATING HBsAg/IgM COMPLEXES IN ACUTE VIRAL HEPATITIS, TYPE B: AN EARLY MARKER OF CHRONIC EVOLUTION

The Lancet ◽  
1982 ◽  
Vol 320 (8294) ◽  
pp. 358-360 ◽  
Author(s):  
Franco Careoda ◽  
Roberto De Franchis ◽  
Antonella D'Arminio Monforte ◽  
Maurizio Vecchi ◽  
Massimo Primignani ◽  
...  
1991 ◽  
Vol 13 ◽  
pp. S11 ◽  
Author(s):  
A. Bertolettl ◽  
C. Ferrari ◽  
A. Penna ◽  
F. Flaccaduri ◽  
H.J. Schlicht ◽  
...  

Author(s):  
Philip P. McGrath ◽  
Lewellys F. Barker ◽  
Francis V. Chisari ◽  
Ruth L. Kirschstein

Blumberg et al. discovered a new antigen in the blood of an Australian aborigine and subsequently this antigen was found to be associated with viral hepatitis type B (serum hepatitis). Serologic and biochemical changes characteristic of viral hepatitis were induced in chimpanzees by inoculation of human serum containing the Hepatitis B Antigen (HB Ag). The light and electron microscopic findings were essentially the same as those of acute viral hepatitis in man. This report will describe the particles in the serum and liver of one animal from that study.One milliliter (ml) of the NIH plasma pool which had been shown to contair. HB Ag was inoculated into a 15 lb. chimpanzee.


Hepatology ◽  
1986 ◽  
Vol 6 (2) ◽  
pp. 337-338
Author(s):  
Shou-Dong Lee ◽  
Jaw-Ching Wu ◽  
Jiin-Yu Wang ◽  
Yang-Te Tsai ◽  
Kwang-Juei Lo ◽  
...  

2009 ◽  
Vol 48 (4) ◽  
pp. 241-243 ◽  
Author(s):  
Keiko Kinomoto ◽  
Yoshinobu Okamoto ◽  
Yuichiro Yuchi ◽  
Masaru Kuriyama

2019 ◽  
Vol 3 (4) ◽  
Author(s):  
Heinz Konrad

Patients with acute viral hepatitis (type A, B, C) should receive high dosage OT at least twice weekly, expecting a fast decline of transaminases and bilirubins, as well as a fast clinical (subjective) recovery. On average, six sessions of OT will suffice. In the author’s experience, this program will avoid the possible chronification of the disease. Patients with chronic viral hepatitis (type B, C) normally require longer treatment, with two OT sessions weekly, for at least six weeks, after which the laboratory work should be remade. A reduction of transaminases is expected to occur, signifying a reduction in the intensity of the ongoing inflammatory process. An OT “maintenance” program is then recommended for at least six months, testing the transaminases regularly. Viral load negativization may or may not occur, but should not be THE goal of this treatment. During the OT, the viral load may vary immensely, and we have no sure explanation for this as yet. The author considers the viral load not to be a reliable criterion for the evaluation of the efficacy of ozone therapy for chronic viral hepatitis. For legal as well as medical reasons, the author recommends NOT to apply ozone therapy and Interferon / Ribavirin treatments at the same time. The real efficacy and long term safety of the newer medicines for acute and chronic viral hepatitis seem very positive, but may / should still be observed / cleared.


Sign in / Sign up

Export Citation Format

Share Document